Atlas Trials

A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight

Clinical trial NCT06973720 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06973720
Sponsor
Pfizer
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ObesityOverweight or Obesity
Start date
2025-04-07
Primary completion
2025-12-16
Enrollment
268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.